Johnson Pharmacare share news, announcements and annual reports
BSE: 532154Commercial Services & SuppliesSmall Cap
JOHNSON PHARMACARE LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1997
Last close ₹0.37₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.37.
30 Oct: open ₹0.38, high ₹0.38, low ₹0.36
52-week range of traded prices to 30 Oct 2026
₹0.36Low, 29 Oct 2026₹0.70High, 24 Nov 2025
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹20 Cr3,837th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 46.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −200.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹14 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −150.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −195.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 49.18
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,61,670
Johnson Pharmacare share news and announcements
460 announcements, routine notices left out, newest first. Page 10 of 10.
Aug 2010
30 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 30, 2010, has appointed Mr. Hiteshkumar M. Patel as Additional Director ....26 Aug · Board Meeting on Aug 30, 2010
Meeting of the Board of Directors of the Company will be held on August 30, 2010, inter alia, to appoint additional director of the ....
Jul 2010
31 Jul · Results
Jun 2010
May 2010
10 May · Results
Mar 2010
25 Mar · Change in Registered Office
25 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 24, 2010 and decisions were taken that Mr. Navneet Singh was appointed ....22 Mar · Board Meeting on Mar 24, 2010
Meeting of the Board of Directors of the Company will be held on March 24, 2010, to appoint additional director of the Company and to ....
Jan 2010
29 Jan · Results